BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 31243055)

  • 1. Alterations of the bile microbiome in primary sclerosing cholangitis.
    Liwinski T; Zenouzi R; John C; Ehlken H; Rühlemann MC; Bang C; Groth S; Lieb W; Kantowski M; Andersen N; Schachschal G; Karlsen TH; Hov JR; Rösch T; Lohse AW; Heeren J; Franke A; Schramm C
    Gut; 2020 Apr; 69(4):665-672. PubMed ID: 31243055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.
    Pereira P; Aho V; Arola J; Boyd S; Jokelainen K; Paulin L; Auvinen P; Färkkilä M
    PLoS One; 2017; 12(8):e0182924. PubMed ID: 28796833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
    Lemoinne S; Kemgang A; Ben Belkacem K; Straube M; Jegou S; Corpechot C; ; Chazouillères O; Housset C; Sokol H
    Gut; 2020 Jan; 69(1):92-102. PubMed ID: 31003979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique bile acid profiles in the bile ducts of patients with primary sclerosing cholangitis.
    Kayashima A; Sujino T; Fukuhara S; Miyamoto K; Kubosawa Y; Ichikawa M; Kawasaki S; Takabayashi K; Iwasaki E; Kato M; Honda A; Kanai T; Nakamoto N
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.
    Rühlemann M; Liwinski T; Heinsen FA; Bang C; Zenouzi R; Kummen M; Thingholm L; Tempel M; Lieb W; Karlsen T; Lohse A; Hov J; Denk G; Lammert F; Krawczyk M; Schramm C; Franke A
    Aliment Pharmacol Ther; 2019 Sep; 50(5):580-589. PubMed ID: 31250469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
    Sabino J; Vieira-Silva S; Machiels K; Joossens M; Falony G; Ballet V; Ferrante M; Van Assche G; Van der Merwe S; Vermeire S; Raes J
    Gut; 2016 Oct; 65(10):1681-9. PubMed ID: 27207975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.
    Olsson R; Björnsson E; Bäckman L; Friman S; Höckerstedt K; Kaijser B; Olausson M
    J Hepatol; 1998 Mar; 28(3):426-32. PubMed ID: 9551680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
    Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis.
    Gauss A; Ehehalt R; Lehmann WD; Erben G; Weiss KH; Schaefer Y; Kloeters-Plachky P; Stiehl A; Stremmel W; Sauer P; Gotthardt DN
    World J Gastroenterol; 2013 Sep; 19(33):5454-63. PubMed ID: 24023488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.
    Quraishi MN; Acharjee A; Beggs AD; Horniblow R; Tselepis C; Gkoutos G; Ghosh S; Rossiter AE; Loman N; van Schaik W; Withers D; Walters JRF; Hirschfield GM; Iqbal TH
    J Crohns Colitis; 2020 Jul; 14(7):935-947. PubMed ID: 32016358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis--a study of bile cultures from ERCP.
    Björnsson ES; Kilander AF; Olsson RG
    Hepatogastroenterology; 2000; 47(36):1504-8. PubMed ID: 11148988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
    Kummen M; Holm K; Anmarkrud JA; Nygård S; Vesterhus M; Høivik ML; Trøseid M; Marschall HU; Schrumpf E; Moum B; Røsjø H; Aukrust P; Karlsen TH; Hov JR
    Gut; 2017 Apr; 66(4):611-619. PubMed ID: 26887816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile Duct Colonization With Enterococcus sp. Associates With Disease Progression in Primary Sclerosing Cholangitis.
    Zigmond E; Zecher BF; Bartels AL; Ziv-Baran T; Rösch T; Schachschal G; Lohse AW; Ehlken H; Schramm C
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1223-1232.e3. PubMed ID: 36116754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
    Shah A; Macdonald GA; Morrison M; Holtmann G
    Am J Gastroenterol; 2020 Jun; 115(6):814-822. PubMed ID: 32250997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary candida infections in primary sclerosing cholangitis.
    Kulaksiz H; Rudolph G; Kloeters-Plachky P; Sauer P; Geiss H; Stiehl A
    J Hepatol; 2006 Nov; 45(5):711-6. PubMed ID: 16979779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.
    Liu Q; Li B; Li Y; Wei Y; Huang B; Liang J; You Z; Li Y; Qian Q; Wang R; Zhang J; Chen R; Lyu Z; Chen Y; Shi M; Xiao X; Wang Q; Miao Q; Fang JY; Gershwin ME; Lian M; Ma X; Tang R
    Gut; 2022 May; 71(5):899-909. PubMed ID: 34035120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
    Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
    J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.
    Kummen M; Thingholm LB; Rühlemann MC; Holm K; Hansen SH; Moitinho-Silva L; Liwinski T; Zenouzi R; Storm-Larsen C; Midttun Ø; McCann A; Ueland PM; Høivik ML; Vesterhus M; Trøseid M; Laudes M; Lieb W; Karlsen TH; Bang C; Schramm C; Franke A; Hov JR
    Gastroenterology; 2021 Apr; 160(5):1784-1798.e0. PubMed ID: 33387530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
    Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
    World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.